Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$44.56
-2.17%
Mkt Cap $2.64B
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (10 analysts)
$60.00
Range $55.00 – $65.00
Implied Upside
+34.6%
Consensus $60.00 vs current $44.56